We therefore aimed to explore the experience of guideline development and particularly the enablers of and barriers to developing evidence-based guidelines in the nine hospitals in South East Asia participating in the SEA-ORCHID project, so as to better understand how evidence-based guideline development could be facilitated in these settings.
In many countries, however, where such structures are less developed or extensive, there are considerable barriers to developing evidence-based guidelines, as identified in the SEA-ORCHID project on the development of maternal and perinatal guideline development in hospitals in South East Asia [ 17].
We aimed to explore the barriers to developing evidence-based guidelines in eleven hospitals in Australia, Indonesia, Malaysia, the Philippines and Thailand, so as to better understand how evidence-based guideline development could be facilitated in these settings.
We therefore aimed to explore the experience of guideline development and particularly the enablers of and barriers to developing and adapting evidence-based guidelines in the nine hospitals in South East Asia participating in the SEA-ORCHID project, so as to better understand how evidence-based guideline development and adaptation could be facilitated in these settings.
However, one of the greatest barriers to developing more clinically useful alert systems is the paucity of empirical evidence of the risk associated with the vast majority of alerts.
Barriers to developing the workforce will be considered.
Our proposal is therefore a call for greater engagement by those from public health, with geneticists and scientists to engage with modern genomic and molecular science to develop evidence-based approaches for addressing translational barriers of the kind identified above.
Perceived barriers to EIPM were lack of knowledge about data sources, inadequate time to develop evidence-informed briefs, and insufficient resources for accessing and managing evidence.
